C-C motif chemokine ligand 24
| chemokine (C-C motif) ligand 24 | |||||||
|---|---|---|---|---|---|---|---|
| Identifiers | |||||||
| Symbol | CCL24 | ||||||
| Alt. symbols | SCYA24, Ckb-6, MPIF-2, eotaxin-2 | ||||||
| NCBI gene | 6369 | ||||||
| HGNC | 10623 | ||||||
| OMIM | 602495 | ||||||
| PDB | 1EIG | ||||||
| RefSeq | NM_002991 | ||||||
| UniProt | O00175 | ||||||
| Other data | |||||||
| Locus | Chr. 7 q11.23 | ||||||
| |||||||
C-C motif chemokine ligand 24 is a protein that in humans is encoded by the CCL24 gene.[5] CCL24 is also known as myeloid progenitor inhibitory factor 2 (MPIF-2) or eosinophil chemotactic protein 2 (eotaxin-2).
Function
[edit]CCL24 belongs to the subfamily of small cytokine CC genes. Cytokines are a family of secreted proteins involved in immunoregulatory and inflammatory processes. The CC cytokines are proteins characterized by two adjacent cysteines. CCL24 interacts with chemokine receptor CCR3 to induce chemotaxis in eosinophils.[6] The cytokine encoded by this gene displays chemotactic activity on resting T lymphocytes, a minimal activity on neutrophils, and is negative on monocytes and activated T lymphocytes. The protein is also a strong suppressor of colony formation by a multipotential hematopoietic progenitor cell line.[7]
Clinical significance
[edit]Elevated levels of eotaxin-2 has been seen in patients with aspirin-exacerbated respiratory disease (AERD), such as asthma. People with lower plasma levels of eotaxin-2 have not been showing tendency to develop aspirin inducible asthma.[8]
References
[edit]- 1 2 3 GRCh38: Ensembl release 89: ENSG00000106178 – Ensembl, May 2017
- 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000004814 – Ensembl, May 2017
- ↑ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ↑ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ↑ "Entrez Gene: C-C motif chemokine ligand 24". Retrieved 2018-05-09.
- ↑ White JR, Imburgia C, Dul E, Appelbaum E, O'Donnell K, O'Shannessy DJ, Brawner M, Fornwald J, Adamou J, Elshourbagy NA, Kaiser K, Foley JJ, Schmidt DB, Johanson K, Macphee C, Moores K, McNulty D, Scott GF, Schleimer RP, Sarau HM (November 1997). "Cloning and functional characterization of a novel human CC chemokine that binds to the CCR3 receptor and activates human eosinophils". J. Leukoc. Biol. 62 (5): 667–75. doi:10.1002/jlb.62.5.667. PMID 9365122. S2CID 12197497.
- ↑ Patel VP, Kreider BL, Li Y, Li H, Leung K, Salcedo T, Nardelli B, Pippalla V, Gentz S, Thotakura R, Parmelee D, Gentz R, Garotta G (April 1997). "Molecular and functional characterization of two novel human C-C chemokines as inhibitors of two distinct classes of myeloid progenitors". J. Exp. Med. 185 (7): 1163–72. doi:10.1084/jem.185.7.1163. PMC 2196270. PMID 9104803.
- ↑ Palikhe NS, Kim SH, Cho BY, Ye YM, Choi GS, Park HS (October 2009). "Genetic variability in CRTH2 polymorphism increases eotaxin-2 levels in patients with aspirin exacerbated respiratory disease". Allergy. 65 (3): 338–346. doi:10.1111/j.1398-9995.2009.02158.x. PMID 19796209. S2CID 205404242.
This article incorporates text from the United States National Library of Medicine, which is in the public domain.
Further reading
[edit]- Papadopoulos NG, Papi A, Meyer J, Stanciu LA, Salvi S, Holgate ST, Johnston SL (July 2001). "Rhinovirus infection up-regulates eotaxin and eotaxin-2 expression in bronchial epithelial cells". Clin. Exp. Allergy. 31 (7): 1060–6. doi:10.1046/j.1365-2222.2001.01112.x. PMID 11467997. S2CID 20581201.
- Tachimoto H, Kikuchi M, Hudson SA, Bickel CA, Hamilton RG, Bochner BS (June 2002). "Eotaxin-2 alters eosinophil integrin function via mitogen-activated protein kinases". Am. J. Respir. Cell Mol. Biol. 26 (6): 645–9. doi:10.1165/ajrcmb.26.6.4741. PMID 12034562.
- Badewa AP, Hudson CE, Heiman AS (September 2002). "Regulatory effects of eotaxin, eotaxin-2, and eotaxin-3 on eosinophil degranulation and superoxide anion generation". Exp. Biol. Med. (Maywood). 227 (8): 645–51. doi:10.1177/153537020222700814. PMID 12192108. S2CID 32212646.
- Menzies-Gow A, Ying S, Sabroe I, Stubbs VL, Soler D, Williams TJ, Kay AB (September 2002). "Eotaxin (CCL11) and eotaxin-2 (CCL24) induce recruitment of eosinophils, basophils, neutrophils, and macrophages as well as features of early- and late-phase allergic reactions following cutaneous injection in human atopic and nonatopic volunteers". J. Immunol. 169 (5): 2712–8. doi:10.4049/jimmunol.169.5.2712. PMID 12193745.
- Chae SC, Lee YC, Park YR, Shin JS, Song JH, Oh GJ, Hong ST, Pae HO, Choi BM, Chung HT (July 2004). "Analysis of the polymorphisms in eotaxin gene family and their association with asthma, IgE, and eosinophil". Biochem. Biophys. Res. Commun. 320 (1): 131–7. doi:10.1016/j.bbrc.2004.05.136. PMID 15207712.
- Chae SC, Park YR, Oh GJ, Lee JH, Chung HT (January 2005). "The suggestive association of eotaxin-2 and eotaxin-3 gene polymorphisms in Korean population with allergic rhinitis". Immunogenetics. 56 (10): 760–4. doi:10.1007/s00251-004-0746-2. PMID 15580493. S2CID 45416407.
- Min JW, Lee JH, Park CS, Chang HS, Rhim TY, Park SW, Jang AS, Shin HD (2005). "Association of eotaxin-2 gene polymorphisms with plasma eotaxin-2 concentration". J. Hum. Genet. 50 (3): 118–23. doi:10.1007/s10038-005-0230-3. PMID 15744457.
- Min JW, Jang AS, Park SM, Lee SH, Lee JH, Park SW, Park CS (November 2005). "Comparison of plasma eotaxin family level in aspirin-induced and aspirin-tolerant asthma patients". Chest. 128 (5): 3127–32. doi:10.1378/chest.128.5.3127. PMID 16304252.
- Park YR, Choi SC, Lee ST, Kim KS, Chae SC, Chung HT (December 2005). "The association of eotaxin-2 and eotaxin-3 gene polymorphisms in a Korean population with ulcerative colitis". Exp. Mol. Med. 37 (6): 553–8. doi:10.1038/emm.2005.68. PMID 16391516.